Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Sentinel node involvement in T0-T1 breast cancers].

D Dequanter1, D Hertens, I Veys

  • 1Service de chirurgie, institut Bordet, 1, rue Héger-Bordet, 1000 Bruxelles, Belgique. didier.dequanter@wanadoo.be

Annales De Chirurgie
|October 26, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The long and winding road to biomarkers for immunotherapy: a retrospective analysis of samples from patients with triple-negative breast cancer treated with pembrolizumab.

ESMO open·2024
Same author

Retrospective study evaluating dental side effects of radiotherapy in patients treated for head and neck cancer.

Journal of stomatology, oral and maxillofacial surgery·2024
Same author

Effective diagnosis and surgical management of primary signet ring cell carcinoma of the eyelid.

Journal of surgical case reports·2023
Same author

Ranula as the First Symptom of HIV Infection in Young Patients.

Case reports in pediatrics·2021
Same author

Risk factors assessment in fibular free flap mandibular reconstruction.

Annales de chirurgie plastique et esthetique·2021
Same author

Farnesoid X receptor as marker of osteotropism of breast cancers through its role in the osteomimetism of tumor cells.

BMC cancer·2020

Sentinel lymph node mapping is feasible for early breast cancer patients. This technique accurately reflects axillary lymph node status, potentially reducing the need for extensive dissections in early-stage T0-T1 breast cancer.

Area of Science:

  • Oncology
  • Surgical Pathology
  • Breast Cancer Research

Background:

  • Axillary lymph node status is critical for early breast cancer diagnosis and treatment planning.
  • Increasingly, early-stage breast cancer diagnoses reveal no lymph node involvement, questioning the necessity of axillary lymph node dissection.
  • Sentinel lymph node biopsy (SLNB) is an alternative to axillary dissection.

Purpose of the Study:

  • To evaluate the feasibility and accuracy of sentinel lymph node (SLN) mapping in patients with T0-T1 breast cancer.
  • To assess the correlation between SLN status and overall axillary lymph node involvement.
  • To explore the implications of SLNB for reducing unnecessary axillary dissections.

Main Methods:

  • A cohort of 84 women with T0-T1 N0 breast cancer were included.

Related Experiment Videos

  • Sentinel lymph node identification was performed using radioisotope injection (53 patients) or blue dye injection (15 patients).
  • All patients underwent axillary dissection; SLNs and other axillary nodes were histologically examined.

    • Main Results:

    • Lymphatic mapping was technically successful.
    • The sentinel lymph node was positive in 15 patients (17.8%), with 10 cases where it was the only positive node.
    • Overall, 26% of patients had metastatic spread to axillary nodes; SLN status generally reflected the status of other axillary nodes.

    Conclusions:

    • Sentinel lymph node mapping is technically achievable in T0-T1 breast cancer.
    • SLN histology appears to be a reliable indicator of the histological status of the remaining axillary lymph nodes.
    • SLNB may help identify patients who can avoid full axillary dissection, but provides no information on other lymph node basins.